http://secfilings.com/News.aspx?tit..._builds_a_better_metformin_mousetrap&naid=273
This is a novelty... a chewable met tab! Err... why? I just swallow the pesky things with my jasmin tea and a huge cake... oops, no, a nice low-carb breakfast etc.
This is worth a read for some other stuff about carbs, skip the usual twaddle intro and get to the point here:
"Boston Therapeutics said that the U.S. Food and Drug Administration approved its petition to file an Abbreviated New Drug Application, or ANDA, for a new, chewable tablet formulation of the diabetes drug metformin hydrochloride. The Company plans to market the new formulation under the name PAZAMET™. An ANDA is an application for a U.S. generic drug approval for an existing licensed medication or FDA-approved drug.
Its active moiety is that of Bristol-Myers Squibb’s approved drug Glucophage Tablets. ..... "the new drug could be available to the pediatric population as well upon marketing approval. "
Dint know about this....
"Harnessing the power of mannans, SUGARDOWN® is taken before carbohydrate-containing meals to reduce the absorption of glucose from the intestinal tract. The proprietary mannan formulation in the chewable tablet binds to carbohydrates and digestive enzymes preventing the breakdown to glucose as the ingredients temporarily coat the digestive tract to slow the absorption of glucose. In addition, SUGARDOWN® induces a feeling of fullness and can therefore support portion control. All of these mechanisms combined lead to lowering the rate of glucose absorption from the intestinal tract into the blood."
ah here we go...
"PAZAMET should be particularly beneficial to the pediatric markets because of the drug being a chewable tablet, rather than a swallowed pill. The geriatric market could also yield a large portion of metformin users immediately to PAZAMET as swallowing, digestive and esophageal problems can be directly overcome with the chewable variation. "
This is a novelty... a chewable met tab! Err... why? I just swallow the pesky things with my jasmin tea and a huge cake... oops, no, a nice low-carb breakfast etc.
This is worth a read for some other stuff about carbs, skip the usual twaddle intro and get to the point here:
"Boston Therapeutics said that the U.S. Food and Drug Administration approved its petition to file an Abbreviated New Drug Application, or ANDA, for a new, chewable tablet formulation of the diabetes drug metformin hydrochloride. The Company plans to market the new formulation under the name PAZAMET™. An ANDA is an application for a U.S. generic drug approval for an existing licensed medication or FDA-approved drug.
Its active moiety is that of Bristol-Myers Squibb’s approved drug Glucophage Tablets. ..... "the new drug could be available to the pediatric population as well upon marketing approval. "
Dint know about this....
"Harnessing the power of mannans, SUGARDOWN® is taken before carbohydrate-containing meals to reduce the absorption of glucose from the intestinal tract. The proprietary mannan formulation in the chewable tablet binds to carbohydrates and digestive enzymes preventing the breakdown to glucose as the ingredients temporarily coat the digestive tract to slow the absorption of glucose. In addition, SUGARDOWN® induces a feeling of fullness and can therefore support portion control. All of these mechanisms combined lead to lowering the rate of glucose absorption from the intestinal tract into the blood."
ah here we go...
"PAZAMET should be particularly beneficial to the pediatric markets because of the drug being a chewable tablet, rather than a swallowed pill. The geriatric market could also yield a large portion of metformin users immediately to PAZAMET as swallowing, digestive and esophageal problems can be directly overcome with the chewable variation. "
